---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-177492"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2023-06-28T23:59:59+00:00"
generated_at: "2026-06-13T15:30:50.676459+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroPace CEO Michael Favet resigns; Joel Becker appointed as new CEO effective July 10, 2023

## Summary
- Michael Favet resigns as CEO and Board member effective July 10, 2023; will provide consulting services for 12 months at $600/hour.
- Joel Becker appointed President and CEO effective July 10, 2023; also joins Board as Class I director through 2025 annual meeting.
- Becker receives base salary of $520,000/year, target bonus of 75% of salary, and option grant of 380,424 shares vesting over 4 years.
- Becker most recently served as President at Viking North Ventures; prior roles include Integer Holdings and St. Jude Medical.
- Favet's unvested equity awards will be cancelled on August 1, 2023; vested options remain exercisable per award agreements.

## SEC filing metadata
- accession: 0001193125-23-177492
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2023-06-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/d506395d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-177492
- JSON: https://secwatch.observer/filing/0001193125-23-177492.json
- Plain text: https://secwatch.observer/filing/0001193125-23-177492.txt

## Key facts
- Executive change
  Michael Favet resigned as Director at NeuroPace Inc.
  - Action: resigned
  - Role: Director
  source text: On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm
- Executive change
  Michael Favet resigned as Chief Executive Officer at NeuroPace Inc.
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm
- Executive change
  Joel Becker was appointed as Director at NeuroPace Inc.
  - Action: appointed
  - Role: Director
  source text: On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm
- Executive change
  Joel Becker was appointed as Chief Executive Officer at NeuroPace Inc.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.